CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Kalifilcon Toric Lens +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06098937
NCT06098937N/ACompleted
CompareCT.gov

Orientation Characteristics of Kalifilcon A Daily Disposable Toric Contact Lenses Compared to Commercially Available Daily Disposable Toric Contact Lenses

Bausch & Lomb Incorporated·interventional·Posted Oct 25, 2023·Updated Dec 10, 2024

In Brief

A clinical study evaluating Kalifilcon Toric Lens, Total1 for Astigmatism, and 2 other interventions for Astigmatism. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Approximately thirty contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAstigmatism
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedOct 25, 2023
Enrollment StartSep 5, 2023
Primary CompletionSep 27, 2023
TodayJul 2, 2026
Enrollment to primary: 22 daysPosted 2.7 years ago

Interventions

Kalifilcon Toric Lensdevice

Kalifilcon A Daily Disposable Toric for Ametropia

Total1 for Astigmatismdevice

Total1 for Astigmatism

Precision1 for Astigmatismdevice

Precision1 for Astigmatism

MyDay Toricdevice

MyDay Toric